Crystal structure of human cathepsin V. 2000

J R Somoza, and H Zhan, and K K Bowman, and L Yu, and K D Mortara, and J T Palmer, and J M Clark, and M E McGrath
Axys Pharmaceuticals, Inc., 385 Oyster Point Boulevard, Suite 1, South San Francisco, California 94080, USA. john_somoza@axyspharm.com

Cathepsin V is a lysosomal cysteine protease that is expressed in the thymus, testis and corneal epithelium. We have determined the 1.6 A resolution crystal structure of human cathepsin V associated with an irreversible vinyl sulfone inhibitor. The fold of this enzyme is similar to the fold adopted by other members of the papain superfamily of cysteine proteases. This study provides a framework for understanding the structural basis for cathepsin V's activity and will aid in the design of inhibitors of this enzyme. A comparison of cathepsin V's active site with the active sites of related proteases revealed a number of differences, especially in the S2 and S3 subsites, that could be exploited in identifying specific cathepsin V inhibitors or in identifying inhibitors of other cysteine proteases that would be selective against cathepsin V.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002403 Cathepsins A group of lysosomal proteinases or endopeptidases found in aqueous extracts of a variety of animal tissues. They function optimally within an acidic pH range. The cathepsins occur as a variety of enzyme subtypes including SERINE PROTEASES; ASPARTIC PROTEINASES; and CYSTEINE PROTEASES. Cathepsin
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

J R Somoza, and H Zhan, and K K Bowman, and L Yu, and K D Mortara, and J T Palmer, and J M Clark, and M E McGrath
June 1998, Protein science : a publication of the Protein Society,
J R Somoza, and H Zhan, and K K Bowman, and L Yu, and K D Mortara, and J T Palmer, and J M Clark, and M E McGrath
April 1997, FEBS letters,
J R Somoza, and H Zhan, and K K Bowman, and L Yu, and K D Mortara, and J T Palmer, and J M Clark, and M E McGrath
February 1997, Nature structural biology,
J R Somoza, and H Zhan, and K K Bowman, and L Yu, and K D Mortara, and J T Palmer, and J M Clark, and M E McGrath
February 1997, Nature structural biology,
J R Somoza, and H Zhan, and K K Bowman, and L Yu, and K D Mortara, and J T Palmer, and J M Clark, and M E McGrath
January 2021, Acta crystallographica. Section F, Structural biology communications,
J R Somoza, and H Zhan, and K K Bowman, and L Yu, and K D Mortara, and J T Palmer, and J M Clark, and M E McGrath
February 2022, Protein science : a publication of the Protein Society,
J R Somoza, and H Zhan, and K K Bowman, and L Yu, and K D Mortara, and J T Palmer, and J M Clark, and M E McGrath
September 2004, Journal of molecular biology,
J R Somoza, and H Zhan, and K K Bowman, and L Yu, and K D Mortara, and J T Palmer, and J M Clark, and M E McGrath
October 2004, Archives of biochemistry and biophysics,
J R Somoza, and H Zhan, and K K Bowman, and L Yu, and K D Mortara, and J T Palmer, and J M Clark, and M E McGrath
November 1993, Thrombosis research,
J R Somoza, and H Zhan, and K K Bowman, and L Yu, and K D Mortara, and J T Palmer, and J M Clark, and M E McGrath
September 2002, Journal of molecular biology,
Copied contents to your clipboard!